ASX - Delayed Quote AUD

Sonic Healthcare Limited (SHL.AX)

Compare
26.20 +0.31 (+1.20%)
At close: 4:10 PM GMT+11
Loading Chart for SHL.AX
DELL
  • Previous Close 25.89
  • Open 25.86
  • Bid 26.17 x --
  • Ask 26.22 x --
  • Day's Range 25.79 - 26.27
  • 52 Week Range 23.58 - 32.57
  • Volume 887,022
  • Avg. Volume 887,320
  • Market Cap (intraday) 12.587B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 24.49
  • EPS (TTM) 1.07
  • Earnings Date Feb 18, 2025 - Feb 24, 2025
  • Forward Dividend & Yield 1.06 (4.05%)
  • Ex-Dividend Date Sep 4, 2024
  • 1y Target Est 27.47

Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

www.sonichealthcare.com

42,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SHL.AX

View More

Performance Overview: SHL.AX

Trailing total returns as of 11/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHL.AX
15.23%
S&P/ASX 200 [XJO]
9.35%

1-Year Return

SHL.AX
7.75%
S&P/ASX 200 [XJO]
17.74%

3-Year Return

SHL.AX
27.18%
S&P/ASX 200 [XJO]
12.48%

5-Year Return

SHL.AX
4.62%
S&P/ASX 200 [XJO]
22.66%

Compare To: SHL.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHL.AX

View More

Valuation Measures

Annual
As of 11/18/2024
  • Market Cap

    12.59B

  • Enterprise Value

    16.46B

  • Trailing P/E

    24.44

  • Forward P/E

    24.81

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.40

  • Price/Book (mrq)

    1.59

  • Enterprise Value/Revenue

    1.84

  • Enterprise Value/EBITDA

    9.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.70%

  • Return on Assets (ttm)

    3.88%

  • Return on Equity (ttm)

    6.80%

  • Revenue (ttm)

    8.97B

  • Net Income Avi to Common (ttm)

    511.09M

  • Diluted EPS (ttm)

    1.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    645M

  • Total Debt/Equity (mrq)

    55.92%

  • Levered Free Cash Flow (ttm)

    427.14M

Research Analysis: SHL.AX

View More

Company Insights: SHL.AX

Research Reports: SHL.AX

View More

People Also Watch